Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Harold C. E. Kluender is active.

Publication


Featured researches published by Harold C. E. Kluender.


Archive | 1995

Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors

Harold C. E. Kluender; Guenter Hans Heinz Herbert Benz; David Ross Brittelli; William H. Bullock; Kerry Jeanne Combs; Brian R. Dixon; Stephan Schneider; Jill Elizabeth Wood; Michael Christopher VanZandt; Donald John Wolanin; Scott M. Wilhelm


Archive | 2006

Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

Julie A. Dixon; Steven Magnuson; Barton Phillips; Yamin Wang; Tindy Li; Kyle Parcella; Jason Newcom; Harold C. E. Kluender; Zhenqiu Hong; Brent Chandler; Zhonghua Zhang; Kristen Allegue; Zhen Liu


Archive | 2002

Oxazolyl-phenyl-2,4-diamino-pyrimidine compounds and methods for treating hyperproliferative disorders

Jacques Dumas; Harold C. E. Kluender; Chengzhi Zhang; Yuanwei Chen; Zhenqiu Hong; Holia Hatoum-Mokdad; Wendy Lee


Archive | 1997

Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Herbert Heinz Benz; Kerry Jeanne Combs; Brian R. Dixon; Michael Christopher VanZandt; Scott M. Wilhelm; Donald John Wolanin; Jill Elizabeth Wood; Stephan Schneider


Archive | 1999

SUBSTITUTED 2-ARYLIMINO HETEROCYCLES AND COMPOSITIONS CONTAINING THEM, FOR USE AS PROGESTERONE RECEPTOR BINDING AGENTS

Brian R. Dixon; Cedo M. Bagi; Catherine Brennan; David R. Brittelli; William H. Bullock; Jinshan Chen; William L. Collibee; Robert Dally; Jeffrey Johnson; Harold C. E. Kluender; William F. Lathrop; Carol Ann Mase; Aniko Redman; William J. Scott; Klaus Urbahns; Donald John Wolanin


Archive | 1995

Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Heinz Herbert Benz; David Ross Brittelli; William H. Bullock; Kerry Jeanne Combs; Brian R. Dixon; Stephan Schneider; Jill Elizabeth Wood; Michael Christopher VanZandt; Donald John Wolanin; Scott M. Wilhelm


Archive | 1999

SUBSTITUTED 4-BIARYLBUTYRIC AND 5-BIARYLPENTANOIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS

Harold C. E. Kluender; David Ross Brittelli; William Riley Schoen; Sookhee Nicole Ha


Archive | 2000

Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity

Jacques Dumas; Holia N. Hatoum-Mokdad; Teddy Kite Joe; Harold C. E. Kluender; Wendy Lee; Dhanapalan Nagarathnam; Robert N. Sibley; Ning Su; Stephen J. Boyer


Archive | 1997

Substituted 4-arylbutyric acid derivatives as matrix metalloprotease

Harold C. E. Kluender; Brian R. Dixon; David Ross Brittelli


Archive | 1998

Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors

Harold C. E. Kluender; Guenter Hans Heinz Herbert Benz; David Ross Brittelli; William H. Bullock; Kerry Jeanne Combs; Brian R. Dixon; Stephan Schneider; Jill Elizabeth Wood; Michael Christopher VanZandt; Donald John Wolanin; Scott M. Wilhelm

Collaboration


Dive into the Harold C. E. Kluender's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julie Dixon

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge